Q. Thermo Fisher Scientific Korea has been a sponsor of BIX for 4 years. For visitors who visit BIX for the first time, could you briefly introduce your company and share the reasons for participating as a sponsor again this year?

A. Thermo Fisher Scientific is a global scientific company achieving over $40 billion in revenue with the help of 100,000 employees worldwide. Guided by our mission to enable our customers to make the world healthier, cleaner, and safer, we support the acceleration of scientific research, solve complex analytical challenges, improve patient diagnostics and therapies, and enhance laboratory productivity. With these goals, we assist Korean companies leading the biopharmaceutical industry with top-notch technology and quality, providing End-to-End services throughout the drug development lifecycle, from solving complex analytical challenges to manufacturing scale-up.

Thermo Fisher Scientific has been participating in BioPlus-Interphex for four consecutive years, showcasing a wide range of in-depth solutions. In particular, we continually launch next-generation solutions related to biopharmaceutical research and production and provide customized technical services tailored to meet customer needs. As part of these efforts, we introduce high-efficiency process technologies, data integration and analysis platforms, and sustainable production solutions. Moving forward, Thermo Fisher Scientific will continue to strive to accelerate innovation for Korean biopharmaceutical companies and enhance their competitiveness in the global market.

Q. We would like to know the key aspects that visitors should not miss at Thermo Fisher Scientific Korea’s booth and sessions this year. Are there any specific products or technologies you would like to showcase? How does this year’s booth compare to your booth at BIX 2023, and what points would you like to emphasize?

A. The domestic biopharmaceutical industry is advancing to a mature stage as it enters an active commercialization phase. As production volume increases, researchers are increasingly demanding solutions that reduce variability and minimize errors in routine and complex repetitive tasks. In response to these changes, Thermo Fisher Scientific Korea offers a broad range of solutions, from automating single-step routine and complex sample processing to entire experimental workflows.

At BIX 2024, we will introduce Thermo Fisher Scientific’s automation systems for the first time. We will showcase actual equipment and software that can integrate with over 450 other devices from various manufacturers. Additionally, we provide total solutions necessary for biopharmaceutical research and production. We invite researchers to visit the Thermo Fisher booth to consult on optimized solutions for various applications, including mammalian and microbial cell culture, downstream processes, and quality control. Experience our diverse range of cell culture-related equipment and consumables firsthand.

Q. Thermo Fisher Scientific Korea pursues sustainable management and engages in the development and production of eco-friendly products. Are there any products at BIX 2024 that showcase your commitment to sustainability?

A. Thermo Fisher is committed to helping make the world healthier, cleaner, and safer through our products and technologies, guided by our corporate mission. We continually seek ways to address environmental and social issues, emphasizing ESG management as a critical standard to achieve a better future. In Korea, we conduct STEM education for students from elementary to university levels and engage in various CSR activities annually. Globally, 41 of our production facilities are ISO 14001 and EMS certified, with all Thermo Fisher employees striving towards a sustainable future, aiming to reduce carbon emissions by 50% by 2030 and achieve Net Zero by 2050.

 Thermo Fisher Scientific Korea is committed to sustainable management, prioritizing the development of eco-friendly products and production processes. At BIX 2024, we will highlight our sustainability efforts through several key products and solutions. The DynaDrive Single-Use Bioreactor reduces packaging usage by up to 27%, minimizing waste. The DynaSpin Single-Use Centrifuge decreases liquid waste by up to 74% and filter waste by up to 69% compared to traditional depth filtration processes. The Labtainer Pro BioProcessing Container reduces packaging usage by 24%. Additionally, Aegis Film is designed without PFAS (per- and polyfluoroalkyl substances), minimizing environmental impact. These products reflect Thermo Fisher Scientific’s commitment to sustainability and support the sustainable future of the Korean biopharmaceutical industry through eco-friendly innovation. You can experience these innovative products firsthand at BIX 2024.
(Related page link:  https://www.thermofisher.com/kr/ko/home/life-science/bioproduction/sustainability.html)

Q. Over the past 5 years of participating in BIX, Thermo Fisher Scientific’s leadership in the industry has contributed to our growth as well. What are your goals for BIX 2024?

A. Thermo Fisher Scientific is making significant investments across the entire spectrum of life sciences. Among these investments, we have been enhancing the production infrastructure for advanced immunotherapies and vaccine raw materials, ensuring that essential medicines are developed safely and swiftly. Additionally, Thermo Fisher Scientific Korea has established a Bioprocess Design Center in Songdo, Incheon, to perfectly replicate biopharmaceutical production processes. Here, the country’s top bioprocess experts support researchers by providing facilities for mammalian and microbial cell culture, cell culture media and buffer preparation rooms, and purification and analysis laboratories, enabling them to experience and understand all stages and knowledge of biopharmaceutical research.

Thermo Fisher Scientific Korea continually supports customers who lead trends in biopharmaceutical process technology and provides life science solutions and services to major pharmaceutical companies. By doing so, we contribute to the development of the Korean bioindustry and the cultivation of talent in related fields.